RxDoctor Payments Data

Michelle Russell, DO

Family Medicine · Centerville, OHNPI 1366428476

Payments from drug & device makers

$699in general payments, 2019–2025

Across 14 payments — averaging $49.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$286
  • Amgen$134
  • Lilly USA, LLC$119
  • Ipsen Biopharmaceuticals, Inc$49
  • AbbVie$41
  • Tempus AI, Inc$40
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$68798%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$699 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$87,279
Medicare patients
223
Services billed
1,867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide108$144,623
FarxigaDapagliflozin Propanediol70$79,493
MounjaroTirzepatide39$54,665
EliquisApixaban52$47,707
JardianceEmpagliflozin27$37,964
ProliaDenosumab18$30,940
Repatha SureclickEvolocumab18$27,267
XareltoRivaroxaban12$19,949
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$17,239
LinzessLinaclotide17$16,743
TrulicityDulaglutide18$16,671
KerendiaFinerenone19$16,374
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$15,779
DapagliflozinDapagliflozin Propanediol15$11,849
Tresiba Flextouch U-200Insulin Degludec13$11,356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$14$144,623108 claims
Lilly USA, LLCMounjaro, Trulicity$119$71,33657 claims
AmgenProlia$134$30,94018 claims
AbbVieLinzess, Synthroid$41$20,31479 claims
BayerKerendia$286$16,37419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Centerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →